“I might have been naive 10 years ago. But now I know exactly where we need to be to deliver returns to shareholders.”
Great find @imback, and @Phaedrus for the missing paragraphs.
The investment case for Mesoblast keeps getting stronger and stronger. This is a lifetime's work that we are supporting. I can wait a bit longer, especially with the great group of fellow investors on this forum. Your support for the company and very personal stories of why you are looking for these therapies to be made available, are as inspiring as SI and the team.
Thank you
Yelrom
The investment case FOR Mesoblast, page-413
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.010(0.91%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.11 | $1.07 | $4.794M | 4.399M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14500 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 141676 | 5 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |